SCHEMBL6203099

SCHEMBL6203099

O=C1CNCc2cc(-c3ccc(F)cc3)c(C=NO)c3ccn1c23

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7158214 0.89 PARP1 (0.32)
SCHEMBL6202057 0.87 GRM2 (0.33) GRM2
SCHEMBL7165369 0.81 PARP1 (0.42) GRM2
SCHEMBL7158050 0.81 PARP1 (0.35) GRM2
SCHEMBL7156783 0.80 PARP1 (0.39) GRM2
SCHEMBL6200931 0.80 PARP1 (0.39) GRM2
SCHEMBL7162610 0.80 PARP1 (0.41) GRM2
SCHEMBL7165443 0.79 GRM2 (0.33) GRM2
SCHEMBL6201527 0.78 PARP1 (0.41) GRM2
SCHEMBL7165011 0.76 PARP1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed